Welcome
Support Centre
22 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Multiple Symptoms Study: a feasibility study of a GP with special interest clinic for patients with multiple medically unexplained symptoms (MMUS)
ISRCTN ISRCTN63083469
ClinicalTrials.gov identifier
Public title Multiple Symptoms Study: a feasibility study of a GP with special interest clinic for patients with multiple medically unexplained symptoms (MMUS)
Scientific title Pilot randomised controlled trial of a GP with special interest clinic for patients with multiple medically unexplained symptoms (MMUS)
Acronym MSS
Serial number at source 2009/P/GP/10
Study hypothesis Feasibility study of a GP with special interest clinic to test the hypothesis that this improves outcomes for patients with multiple medically unexplained symptoms (MMUS).
Lay summary
Ethics approval Added 20/01/2010:
South East Scotland Research Ethics Committee 2 gave a favourable opinion to the study on 23rd September 2009. Amendments to the protocol were approved on the 18th November 2009.
Study design Pilot randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Medically unexplained symptoms/ somatisation
Participants - inclusion criteria Patients will be eligible for inclusion if they are aged 18-64 (both males and females) and meet all of the following four criteria:
1. They have been referred at least twice to hospital outpatients in the last three years. Where referral data is only available for shorter periods the number of referrals required may be reduced.
2. Their general practice electronic notes summary does not contain any of a list of diagnostic codes representing serious illness (coronary heart disease, stroke, cancer, severe mental illness)
3. Their general practice electronic notes summary contains one or more diagnostic codes potentially indicating an MUS disorder. These codes include both MUS syndromes (e.g. fibromyalgia, irritable bowel syndrome, tension headache) and specific codes for a negative investigation which is commonly carried out for symptoms (e.g. normal endoscopy)
4. Have a Patient Health Questionnaire-14 (PHQ-14) score of >9
Participants - exclusion criteria 1. They are unable to provide informed consent to participate
2. Their GP regards their participation as clinically inappropriate
3. In the opinion of their GP, they either have a serious illness (e.g. heart disease, cancer, serious mental illness) which was not picked up on the database search or have other medical diagnoses which can fully explain their PHQ-14 score
4. They have serious illness related disability (for instance receiving daily personal care or using a wheelchair)
5. They are likely to have difficulty communicating by telephone
6. They are likely to have difficulty completing the forms and questionnaires
7. They express significant suicidal thoughts (PHQ-9 question 9 scoring >1)
8. They are currently undergoing multidisciplinary rehabilitation or management (e.g. pain clinic)
9. They are currently undergoing specialist psychological treatment
Anticipated start date 01/10/2009
Anticipated end date 30/04/2010
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants Phase 1: 120; Phase 2: approximately 30
Interventions Phase 1 will consist of i) trial of search criteria to identify patients with MUSS, ii) a postal study using the symptoms checklist (PHQ 14). Patients who score 10 or more will be regarded as potential participants for the Phase 2 pilot clinic.

Phase 2 will pilot the Multiple Symptoms Clinic. This will consist of a baseline assessment and then randomisation to either the Symptoms Clinic or usual care. The Symptoms Clinic will consist of an initial one hour consultation followed up at fortnightly intervals by three further twenty minute consultations.

Details of Joint Sponsor:
NHS Lothian
Queens Medical Research Institute
Research and Development Office
47 Little France Crescent
Edinburgh
EH6 4TJ
United Kingdom
Tel: 0131 242 3300
Fax: 0131 242 3343
Email: R&DOffice@luht.scot.nhs.uk
Primary outcome measure(s) Assess feasibility of this approach for a larger efficacy trial. Patient outcomes to be evaluated include PHQ-14, PHQ- 9 (depression) GAD-7 (anxiety) and SF-12 (health status) and a single item self-rated improvement measure, the Patient Global Impression of Change (PGIC).

Primary outcomes will be measured 12 weeks after randomisation.
Secondary outcome measure(s) Follow up interviews. Patients who have been seen in the Symptoms Clinic will be invited to be interviewed, in a place of their choice or by telephone, by a member of the research team. The aim of the semi-structured interviews will be to elicit patients views on the identification process, the conduct of this pilot study and the content of the Symptoms Clinic.

Secondary outcomes/the follow up interviews will take place at the same time as the primary outcome measures or as soon as possible thereafter.
Sources of funding Chief Scientist Office, the Scottish Government (UK) (ref: CZG/2/412)
Trial website
Publications
Contact name Dr  Christopher  Burton
  Address Centre for Population Health Sciences
University of Edinburgh
20 West Richmond Street
  City/town Edinburgh
  Zip/Postcode EH8 9DX
  Country United Kingdom
  Email chris.burton@ed.ac.uk
Sponsor University of Edinburgh (UK)
  Address Research Governance Office
Queens Medical Research Institute
47 Little France Crescent
  City/town Edinburgh
  Zip/Postcode EH6 4TJ
  Country United Kingdom
  Tel +44 (0)131 242 9461
  Fax +44 (0)131 242 9447
  Email e.currie@ed.ac.uk
  Sponsor website: http://www.ed.ac.uk/home
Date applied 01/09/2009
Last edited 20/01/2010
Date ISRCTN assigned 08/10/2009
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central